Related Experiment Videos
Reply to: Behçet's disease: an MHC-I-opathy?
Dennis McGonagle1, Sibel Zehra Aydin2, Ahmet Gül3
1Section of Musculoskeletal Diseases, The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Chapel Allerton Hospital, Leeds, UK.
Clinical and Experimental Rheumatology
|April 20, 2017
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
CD163: a potential biomarker for lupus nephritis activity.
Lupus science & medicine·2026
Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behçet's disease.
Annals of the rheumatic diseases·2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.
Annals of the rheumatic diseases·2026
Long-term risk of malignancies in ANCA-associated vasculitis.
EULAR rheumatology open·2026
Outcome and risk factors for progression in IgG4-related disease under watchful waiting.
Clinical and experimental rheumatology·2026
Safety and procedural success of minor salivary gland biopsy in Sjögren's disease: a retrospective analysis of 202 patients.
Clinical and experimental rheumatology·2026
AI-augmented rheumatologist? Reflections on AI-induced technostress, job insecurity and professional identity.
Clinical and experimental rheumatology·2026
The role of phospholipase D4 in inflammatory autoimmune diseases.
Clinical and experimental rheumatology·2026
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms.
Clinical and experimental rheumatology·2026
Empathy and Love as Protective Factors in Opioid Use Disorder Recovery.
Journal of psychoactive drugs·2026